(Q24304472)

regulation of cell population proliferation

GOA release 2020-03-11

1 reference

Molecular and Cellular Biochemistry

GOA release 2020-03-11

1 reference

Biao Yan

1

0 references

language of work or name

English

0 references

publication date

November 2011

0 references

published in

0 references

volume

357

0 references

issue

1-2

0 references

page(s)

39-45

0 references

cites work

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Mammalian mitochondrial IAP binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

The inhibitor of apoptosis protein family and its antagonists in acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Livin, a novel inhibitor of apoptosis protein family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

KIAP, a novel member of the inhibitor of apoptosis protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

RING domain E3 ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Transcriptional regulation of livin by beta-catenin/TCF signaling in human lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Livin gene plays a role in drug resistance of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Livin/ML-IAP as a new target for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Telomere-based DNA damage responses: a new approach to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Strategies for silencing human disease using RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Detection of anti-livin antibody in gastrointestinal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Regulators of apoptosis: suitable targets for immune therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0873-7

Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer

21 January 2018

1 reference

12 December 2020

Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

1 reference

12 December 2020

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients

1 reference

12 December 2020

Livin and Bcl-2 expression in high-grade osteosarcoma

1 reference

12 December 2020

Isolation of peptides blocking the function of anti-apoptotic Livin protein

1 reference

12 December 2020

Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells

1 reference

12 December 2020

CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation

1 reference

12 December 2020

The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity

1 reference

12 December 2020

Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.

1 reference

12 December 2020

Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.

1 reference

12 December 2020

An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif

1 reference

12 December 2020

Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.

1 reference

12 December 2020

MycN is a transcriptional regulator of livin in neuroblastoma.

1 reference

12 December 2020

Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome

1 reference

12 December 2020

Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

1 reference

12 December 2020

Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.

1 reference

12 December 2020

Prognostic value of Survivin and Livin in nasopharyngeal carcinoma

1 reference

12 December 2020